AALL1731_A Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)

IRB/UVA Tracking #
21760
Contact
Candace K Hudspeth
Contact Email
Contact Phone
1.434.982.1091
Phase
III
Primary purpose
Treatment
Cancer PI
William C. Petersen
Status
OPEN TO ACCRUAL
Ages
Children